# Prognostic Immune Biomarkers in HNSCC

> **NCT05941676** · — · COMPLETED · sponsor: **University Hospital Ostrava** · enrollment: 55 (actual)

## Conditions studied

- Head and Neck Cancer
- Squamous Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Tumour immunoprofile evaluation

## Key facts

- **NCT ID:** NCT05941676
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2022-08-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05941676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05941676, "Prognostic Immune Biomarkers in HNSCC". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05941676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*